ID   CRB3_RAT                Reviewed;         277 AA.
AC   B2GV72;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 1.
DT   24-JAN-2024, entry version 114.
DE   RecName: Full=Carbonyl reductase [NADPH] 3 {ECO:0000305};
DE            EC=1.1.1.184 {ECO:0000269|PubMed:18983987};
DE   AltName: Full=Monomeric carbonyl reductase 3 {ECO:0000303|PubMed:18983987};
DE   AltName: Full=Quinone reductase CBR3;
DE            EC=1.6.5.10 {ECO:0000250|UniProtKB:O75828};
GN   Name=Cbr3 {ECO:0000312|RGD:1309728};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF TRP-230, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18983987; DOI=10.1016/j.cbi.2008.10.005;
RA   Miura T., Itoh Y., Takada M., Tsutsui H., Yukimura T., Nishinaka T.,
RA   Terada T.;
RT   "Investigation of the role of the amino acid residue at position 230 for
RT   catalysis in monomeric carbonyl reductase 3.";
RL   Chem. Biol. Interact. 178:211-214(2009).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of carbonyl compounds
CC       to their corresponding alcohols. Has low NADPH-dependent oxidoreductase
CC       activity (PubMed:18983987). Acts on several orthoquinones, as well as
CC       on non-quinone compounds, such as isatin or on the anticancer drug
CC       oracin. Best substrates for CBR3 is 1,2- naphthoquinone, hence could
CC       play a role in protection against cytotoxicity of exogenous quinones.
CC       Exerts activity toward ortho-quinones but not paraquinones. No
CC       endogenous substrate for CBR3 except isatin has been identified (By
CC       similarity). {ECO:0000250|UniProtKB:O75828,
CC       ECO:0000269|PubMed:18983987}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a secondary alcohol + NADP(+) = a ketone + H(+) + NADPH;
CC         Xref=Rhea:RHEA:19257, ChEBI:CHEBI:15378, ChEBI:CHEBI:17087,
CC         ChEBI:CHEBI:35681, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.184; Evidence={ECO:0000269|PubMed:18983987};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:19259;
CC         Evidence={ECO:0000250|UniProtKB:O75828};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADPH = a quinol + NADP(+);
CC         Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124;
CC         EC=1.6.5.10; Evidence={ECO:0000250|UniProtKB:O75828};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46165;
CC         Evidence={ECO:0000250|UniProtKB:O75828};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.5 nM for 4-benzoylpyridine {ECO:0000269|PubMed:18983987};
CC         Note=kcat is 14 min(-1) with 4-benzoylpyridine as substrate
CC         (PubMed:18983987). kcat is 0.030 min(-1) with menadione as substrate
CC         (PubMed:18983987). {ECO:0000269|PubMed:18983987};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O75828}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000305}.
CC   -!- CAUTION: There are conflicting results on the ability of CBR3 to
CC       metabolize menadione. Although menadione was originally reported as a
CC       good substrate of CBR3 (By similarity). Results of later studies showed
CC       that CBR3 possesses very low or no activity toward menadione
CC       (PubMed:18983987). {ECO:0000250|UniProtKB:O75828,
CC       ECO:0000269|PubMed:18983987}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07033657; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474083; EDL76737.1; -; Genomic_DNA.
DR   EMBL; BC166553; AAI66553.1; -; mRNA.
DR   RefSeq; NP_001100580.1; NM_001107110.1.
DR   AlphaFoldDB; B2GV72; -.
DR   SMR; B2GV72; -.
DR   STRING; 10116.ENSRNOP00000002310; -.
DR   iPTMnet; B2GV72; -.
DR   PhosphoSitePlus; B2GV72; -.
DR   jPOST; B2GV72; -.
DR   PaxDb; 10116-ENSRNOP00000002310; -.
DR   PeptideAtlas; B2GV72; -.
DR   Ensembl; ENSRNOT00000002310.7; ENSRNOP00000002310.4; ENSRNOG00000001701.7.
DR   GeneID; 304078; -.
DR   KEGG; rno:304078; -.
DR   UCSC; RGD:1309728; rat.
DR   AGR; RGD:1309728; -.
DR   CTD; 874; -.
DR   RGD; 1309728; Cbr3.
DR   eggNOG; KOG1208; Eukaryota.
DR   GeneTree; ENSGT00940000162541; -.
DR   HOGENOM; CLU_010194_9_0_1; -.
DR   InParanoid; B2GV72; -.
DR   OMA; YWANDSV; -.
DR   OrthoDB; 3346557at2759; -.
DR   PhylomeDB; B2GV72; -.
DR   TreeFam; TF329359; -.
DR   BRENDA; 1.1.1.184; 5301.
DR   Reactome; R-RNO-211945; Phase I - Functionalization of compounds.
DR   PRO; PR:B2GV72; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Proteomes; UP000234681; Chromosome 11.
DR   Bgee; ENSRNOG00000001701; Expressed in stomach and 19 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0000253; F:3-keto sterol reductase activity; IDA:RGD.
DR   GO; GO:0004090; F:carbonyl reductase (NADPH) activity; IDA:RGD.
DR   GO; GO:0070402; F:NADPH binding; ISO:RGD.
DR   GO; GO:0008753; F:NADPH dehydrogenase (quinone) activity; ISS:UniProtKB.
DR   GO; GO:0050890; P:cognition; ISO:RGD.
DR   GO; GO:0042376; P:phylloquinone catabolic process; IDA:RGD.
DR   CDD; cd05324; carb_red_PTCR-like_SDR_c; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR045313; CBR1-like.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PANTHER; PTHR43963; CARBONYL REDUCTASE 1-RELATED; 1.
DR   PANTHER; PTHR43963:SF3; CARBONYL REDUCTASE [NADPH] 3; 1.
DR   Pfam; PF00106; adh_short; 2.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   CHAIN           2..277
FT                   /note="Carbonyl reductase [NADPH] 3"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K354"
FT                   /id="PRO_0000455424"
FT   ACT_SITE        194
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT   BINDING         10..34
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:O75828"
FT   BINDING         38..42
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:O75828"
FT   BINDING         63..64
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:O75828"
FT   BINDING         90
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:O75828"
FT   BINDING         140
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         194..198
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:O75828"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48758"
FT   MUTAGEN         230
FT                   /note="W->P: Does not affect carbonyl reductase (NADPH)
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:18983987"
SQ   SEQUENCE   277 AA;  30841 MW;  05DBA2BCCD985EB0 CRC64;
     MSSCSRVALV TGANKGIGFA ITRDLCRKFS GDVVLTARDE ARGRAAVKQL QAEGLSPRFH
     QLDIDNPQSI RALRDFLRKE YGGLNVLVNN AGIAFRMDDP TPFDVQAEVT LKTNFFATRN
     VCTELLPIMK PHGRVVNVSS LQGLKALENC SEDLQERFRC DTLTEGDLVD LMKKFVEDTK
     NEVHEREGWP DSAYGVSKLG VTVLTRILAR QLDEKRKADR ILLNACCPGW VKTDMARDQG
     SRTVEEGAET PVYLALLPPD ATEPHGQLVR DKVVQTW
//
